about
Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesityResistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity.A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea.Lifetime obesity in patients with eating disorders: increasing prevalence, clinical and personality correlatesImpact of OSA on biological markers in morbid obesity and metabolic syndrome.Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus.Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism.Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro.Psychological and Personality Predictors of Weight Loss and Comorbid Metabolic Changes After Bariatric Surgery.Paired subcutaneous and visceral adipose tissue aquaporin-7 expression in human obesity and type 2 diabetes: differences and similarities between depots.Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?Streptococcus bovis meningitis in a healthy adult patient.Maternal and perinatal outcomes after bariatric surgery: a Spanish multicenter study.[Is the morbid obesity surgery profitable in times of crisis? A cost-benefit analysis of bariatric surgery].Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors.Eating-related environmental factors in underweight eating disorders and obesity: are there common vulnerabilities during childhood and early adolescence?Loss of control over eating: a description of the eating disorder/obesity spectrum in women.Long-Term Outcomes in Patients with Morbid Obesity and Type 1 Diabetes Undergoing Bariatric Surgery.Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication.Obstructive sleep apnoea and metabolic impairment in severe obesity.EndoBarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism.Is Roux-en-Y gastric bypass adequate in the super-obese?Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women.Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity studyIL-18: relationship with anthropometry, body composition parameters, leptin and arterial hypertensionDistribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy populationLMNA mRNA expression is altered in human obesity and type 2 diabetesLow 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variablesEvaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-upBariatric surgery and bone mineral metabolismNew Metrics to Assess Type 2 Diabetes After Bariatric Surgery: The "Time-Within-Remission Range"Changes in Bone Mineral Density in Patients with Type 2 Diabetes After Different Bariatric Surgery Procedures and the Role of Gastrointestinal HormonesLong-Term Effects in Bone Mineral Density after Different Bariatric Procedures in Patients with Type 2 Diabetes: Outcomes of a Randomized Clinical Trial
P50
Q28299330-CFEF0D38-8F91-47DB-A766-2E8DF064BCD4Q34330489-30147F69-056A-4121-A787-50B5C15A4944Q34337604-C7689463-69E7-4F62-920A-6869C462F44DQ36369792-3AFD9380-9E8D-4F60-9F0D-5AA9A21C46A6Q36434397-E89CCE82-2363-42C7-891D-9D890236CE30Q37590178-E70F342B-F1D2-40D7-A9FA-7A729324F779Q37726612-E1C0D001-DF08-4992-B603-50E90139FBC4Q39025428-A4B2CCBE-E4C0-4A03-82AE-4F26188BFBCBQ39549540-D4A6F652-4AE4-4E75-A349-21AA1DD70CD6Q39994725-7AE9E293-4600-4BBA-AC03-DC742B07A731Q41350098-ECD6B710-7D4B-4003-9EFF-8DE0F5D69113Q42170319-B1CF9B45-2063-461E-8DB1-501E0A3F35DCQ42838086-AC515C13-160D-4E51-B330-55120AC0D553Q43902511-A57F4391-4C87-4388-AE77-1BF94ADA694EQ44413424-E7DCA2B3-9086-4283-A2F6-B136C2352D7EQ45237180-94A83A37-C725-446A-8C51-25AB4CEDE4E2Q46535848-42FCBD39-2B7C-4688-817B-66E2C74BD896Q46701754-BB713FC3-87A9-40C2-AAC1-40AF8A7BB61EQ46795285-0815151A-DFD6-4605-95C3-D19503EC86CAQ47809289-7767F85E-E662-4CCA-AC50-B47074D834CEQ48220785-3A113623-E074-4763-8359-85951C5126C7Q48300689-D74221CE-581F-43E8-A046-2C922980085EQ48301896-A8188CBA-8B49-4BDA-9F7B-198655B2A570Q48505394-26FBCF22-027A-43EA-913A-F3AF29F5D136Q51837216-9412D33A-E413-4630-878C-72154854CD28Q79986532-D2FEACDA-83DB-4DD8-9E80-15B41E921ECFQ80187195-66A9BC33-C4C3-45A8-B698-27BE22B2D10FQ81103628-995D45E9-F06A-4F84-8DB6-291F934C1E18Q81323297-9ECEECE1-B341-42CF-8032-AC2E8C566F8FQ81411518-935AB5C5-3EC3-46F1-A90B-B73F9A3EBD89Q83045422-95CA4CFA-1B6A-4CD0-8BEE-0EE07EA26F75Q87917341-211C5E92-1316-4C34-8494-AA398892B54BQ91869041-9CEAB15D-0576-487E-99A6-C208E4F54C00Q92669900-3F4DB9B0-C75D-47A9-B57B-8504B2AF40C9Q96428103-2DCB4B7F-14D4-43B7-A50B-27CABE7511A2
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nuria Vilarrasa
@ast
Nuria Vilarrasa
@en
Nuria Vilarrasa
@es
Nuria Vilarrasa
@nl
Nuria Vilarrasa
@sl
type
label
Nuria Vilarrasa
@ast
Nuria Vilarrasa
@en
Nuria Vilarrasa
@es
Nuria Vilarrasa
@nl
Nuria Vilarrasa
@sl
prefLabel
Nuria Vilarrasa
@ast
Nuria Vilarrasa
@en
Nuria Vilarrasa
@es
Nuria Vilarrasa
@nl
Nuria Vilarrasa
@sl
P106
P1153
56197842800
P21
P31
P496
0000-0003-3188-1990